SpaceOAR
Company

Last deal

$6M

Amount

Series E

Stage

13.07.2016

Date

3

all rounds

$42.9M

Total amount

date founded

Financing round

General

About Company
SpaceOAR develops hydrogels for radiation therapy and cancer surgery.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Augmenix

founded date

01.01.2007

Number of employees

Company Type

For Profit

Last funding type

Series E

IPO status

Private

Description

The Bedford, Massachusetts-based medical device company, founded in 2007, creates space-filling hydrogels designed to minimize the side effects of radiation therapy and protect the quality of life for prostate cancer patients. The clinically proven hydrogel enables healthcare providers to reduce urinary, sexual, and bowel side effects, resulting in a better patient experience. SpaceOAR is a privately held company that focuses on developing hydrogels for radiation oncology and cancer surgery indications.
Contacts
Similar Companies
997
B dot Medical

B dot Medical

The medical company develops an ultra-compact proton cancer therapy system.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Edogawa City, Tokyo, Japan

total rounds

2

total raised

$4.3M
ViewRay

ViewRay

ViewRay develops advanced radiation therapy technology for cancer treatment.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical, Medical Device

Location

Oakwood, OH 44146, USA

total rounds

21

total raised

$877.79M
Moximed

Moximed

Moximed develops implants for knee osteoarthritis patients, reducing joint pain and improving mobility.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Hayward, CA, USA

total rounds

8

total raised

$143.22M
RefleXion Medical

RefleXion Medical

RefleXion Medical develops biologically-guided radiotherapy systems for cancer patients.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Hayward, CA, USA

total rounds

11

total raised

$675.1M
M&A Details
1

Acquired by

Boston Scientific

announced date

07.09.2018

price

$600M

Financials

Funding Rounds
7
3

Number of Funding Rounds

$42.9M

Money Raised

Their latest funding was raised on 13.07.2016. Their latest investor Sparta Group. Their latest round Series E

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Catalyst Health Ventures

Catalyst Health Ventures

Catalyst Health Ventures is a Boston-based venture capital firm that invests in disruptive solutions for unmet healthcare needs.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Boston, MA, USA

count Of Investments

46

count Of Exists

10
Catalyst Health Ventures

Catalyst Health Ventures

Catalyst Health Ventures is a Boston-based venture capital firm that invests in disruptive solutions for unmet healthcare needs.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Boston, MA, USA

count Of Investments

46

count Of Exists

10
Excelestar Ventures

Excelestar Ventures

Excelestar Ventures is a global venture capital firm based in Andover, Massachusetts.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Andover, MA, USA

count Of Investments

16

count Of Exists

4
Varian

Varian

Varian Medical Systems is a global leader in manufacturing medical devices and software for treating cancer and other medical conditions.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Manufacturing

Location

Palo Alto, CA, USA

count Of Investments

13

count Of Exists

1
Co-Investors
Investors
9
4

Number of lead investors

9

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series B
Yes
Debt Financing, Series B
Yes
Debt Financing, Series B, Series D, Series E
Sparta Group

Sparta Group

Sparta Group invests in startups and technology companies.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Venture Capital, Financial Services, Finance

Location

Stoneham, MA, USA

count Of Investments

11

count Of Exists

1
Ascension Ventures

Ascension Ventures

Ascension is an early-stage venture capital firm backing tech and impact founders.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Health Care, Venture Capital, Therapeutics

Location

Clarkton, MO 63837, USA

count Of Investments

86

count Of Exists

24
Tara Butler

Tara Butler

Tara Butler joined AHV in 2002 after completing a residency in obstetrics and gynecology at Washington University in St. Louis. She primarily focuses on investments in the medical device and diagnostics sector. Tara has been a board member or observer at several AHV portfolio companies, including Augmenix, CHF Solutions, Confluent Surgical, HemoSphere, Interventional Spine, ISTO Technologies, MindFrame, Neurolutions, Novasys, Ocular Therapeutix, OptiScan Biomedical, PathoGenetix, Stereotaxis (NASD:STXS), and TomoTherapy (NASD:TOMO). Prior to attending medical school, she held positions in business development at Medtronic, in finance at Honeywell and as a laboratory research assistant at the University of Pennsylvania School of Medicine. She holds a BS in Economics and an MBA from the Wharton School of Business at the University of Pennsylvania, and a Doctor of Medicine from the University of Pennsylvania School of Medicine.

current job

Ascension Ventures
Ascension Ventures
Catalyst Health Ventures

Catalyst Health Ventures

Catalyst Health Ventures is a Boston-based venture capital firm that invests in disruptive solutions for unmet healthcare needs.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Boston, MA, USA

count Of Investments

46

count Of Exists

10

People

Founders
1
Amarpreet Sawhney
Amarpreet Sawhney

Amarpreet Sawhney

Amar is the President and CEO of Octux, Inc. a company focused on unmet needs in ophthalmic surgical wound closure and drug delivery. Previously, he was Founder and CEO of Confluent Surgical (acquired by Covidien), a biosurgery company. He was Chairman of marketRx (acquired by Cognizant), a provider of pharmaceutical marketing and sales analytics and intelligence. Before Confluent, Amar was the technology founder of Focal, Inc. (acquired by Genzyme). Amar’s innovations are the subject of almost 100 issued and pending patents. He is a board member of Soteira, Square One and TiE Boston. He is a board member and founder of Access Closure, Octux, Augmenix, and Incept LLC. Amar volunteers his time with entrepreneurial organizations including TiE Boston, MassMedic, and the E&Y Entrepreneur of the Year program. Amar and Confluent have been recognized with awards including MassMedic best startup company award, Frost and Sullivan Product innovation award, MIT Global Indus Technovators Award, E&Y regional entrepreneur of the year award, Mass High Tech All Star award, and University of Texas Outstanding Young Engineering Graduate award. Amar holds a Ph.D. and M.S. in Chemical Engineering from the University of Texas at Austin and a B.Tech. in Chemical Engineering from the Indian Institute of Technology, New Delhi.

current job

Instylla
Instylla

count Of Investments

1

Amarpreet Sawhney

Employee Profiles
4

Yasemin Dalgali

Director

John Pedersen

John Pedersen

CEO

Amarpreet Sawhney

Amarpreet Sawhney

President and CEO

Jim Fortune

COO

Activity

Recent News
0